#VisualAbstract: Nivolumab plus ipilimumab may be less effective in females with melanoma compared to males
Click to read this study in JAMA Network Open.
Click to read this study in JAMA Network Open.
1. Pathologists demonstrated high accuracy in diagnosing melanocytic lesions using the Management of Lesions to Exclude Melanoma (MOLEM) classification system ...
Click to read the study in Clinical Cancer Research.
Click to read the study in the Journal of Investigative Dermatology.
Click to read the study in the European Journal of Cancer.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.